Targeting and imaging of HER2 overexpression tumor with a new peptide-based 68Ga-PET radiotracer

This publication has 40 references indexed in Scilit:

• Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts
  PLOS ONE, 2013
• In vitro and in vivo evaluation of selected 68Ga-siderophores for infection imaging
  Nuclear Medicine and Biology, 2012
• HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis
  Breast Cancer Research and Treatment, 2011
• Molecular Design and Optimization of ^99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
  Journal of Nuclear Medicine, 2011
• Target-specific delivery of peptide-based probes for PET imaging
  Advanced Drug Delivery Reviews, 2010
• A 2-Helix Small Protein Labeled with ⁶⁸Ga for PET Imaging of HER2 Expression
  Journal of Nuclear Medicine, 2009
• On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a ¹²⁴I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
  Journal of Nuclear Medicine, 2009
• Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments
  Nuclear Medicine and Biology, 2005
• Preclinical characterisation of ¹¹¹In‐DTPA‐trastuzumab
  British Journal of Pharmacology, 2004
• Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
  The FASEB Journal, 2002